Results 231 to 240 of about 396,796 (347)

Upadacitinib for difficult‐to‐treat paediatric Crohn's disease

open access: yesJPGN Reports, EarlyView.
Abstract Paediatric‐onset inflammatory bowel disease (IBD) has an enormous impact on healthcare systems as it translates to a lifetime of healthcare. Since the approval of anti‐tumour necrosis factor‐alpha agents, it has become evident that in the long journey of paediatric IBD, there is an absolute need for more treatment options.
N. Nedelkopoulou   +3 more
wiley   +1 more source

A case of Corynebacterium propinquum microbial keratitis after amniotic membrane transplantation. [PDF]

open access: yesBMC Ophthalmol
Yukari Y   +5 more
europepmc   +1 more source

Impact of biologic induction dose and concomitant drugs on anti‐drug antibody formation in a pediatric IBD cohort with high Hispanic representation

open access: yesJPGN Reports, EarlyView.
Abstract Objectives The use of biologic therapy is increasing in pediatric patients with inflammatory bowel disease (IBD). However, efficacy may be compromised by increased drug clearance and anti‐drug antibodies (ADAs). Historically, concomitant immunomodulator therapy (CIT) has been used to prevent ADA formation. Pediatric studies evaluating CIT have
Kenneth Grant   +3 more
wiley   +1 more source

Repurposing drugs to advance the treatment of Buruli ulcer. [PDF]

open access: yesAntimicrob Agents Chemother
Singh S   +3 more
europepmc   +1 more source

Incidence and characteristics of pediatric patients with Crohn's disease undergoing surgery: A cross‐sectional study

open access: yesJPGN Reports, EarlyView.
ABSTRACT Objectives Despite biological treatments reducing the burden of pediatric inflammatory bowel disease, many patients still require surgery. Data on pediatric patient characteristics and surgical incidence are limited, often based on adult studies.
Hugo Gagnon   +6 more
wiley   +1 more source

Tuberculosis of the tongue in a patient with rheumatoid arthritis treated with methotrexate and adalimumab. [PDF]

open access: yes, 2014
Assante LR   +5 more
core  

COLLAB: A Global Survey of Clinical and Laboratory Assessment in Alopecia Areata by Hair Specialists

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Alopecia areata (AA) is a common non‐scarring alopecia. Data continue to emerge on associations with autoimmune and other conditions. Janus kinase inhibitors (JAKi) are increasingly used to treat AA. Objectives The aim was to assess variation in laboratory testing in patients with AA among hair experts internationally and to compare
Cathal O'Connor   +39 more
wiley   +1 more source

Home - About - Disclaimer - Privacy